$BURU -NUBURU and Tekne Begin Production of GRAELION

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
193
$BURU -NUBURU and Tekne Begin Production of GRAELION Platform for Ukraine, Launching Phase 1 Revenue

Prototype Enters Manufacturing as Program Moves into Execution with €5–10M Initial Revenue and Visibility Toward €80–120M Steady-State

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, electronic warfare and software-orchestrated defense systems, today announced that its Ukraine initiative with Tekne S.p.A. (“Tekne”) and Engineering Bureau “BERYL” LLC (“Beryl”), an established Ukrainian industrial company actively producing and supplying vehicles to Ukrainian military forces, has entered the production phase under an executing industrial program supporting Ukraine deployment activities.

Following the execution of the strategic cooperation agreement, the initiative has advanced into active manufacturing, with the first GRAELION tactical prototype entering the production line, as formally certified by Tekne in an official industrial progress declaration dated March 17, 2026.

Transition to Executing Program

The advancement into production marks a clear transition from structured agreement to executing industrial program and initiates contract-linked revenue activities associated with prototype manufacturing, qualification, and initial deployment. The program is aligned with Phase 1 revenue objectives in the €5–10 million range and provides visibility toward scaled deployment as production ramps.

The program builds on established operational and industrial foundations. GRAELION vehicles are already deployed in Ukraine with the State Emergency Service (DSNS) for demining operations, while an existing military-grade configuration has been commercialized in Italy. Beryl serves as an active Ukrainian industrial supplier supporting defense requirements.

Execution Framework

First GRAELION tactical prototype entered into production line.
Industrial supply chain and manufacturing protocols validated.
Platform configured for Ukrainian military qualification.
Coordinated execution with in-country industrial partner Beryl.
Visibility toward €80–120 million scaled program potential.
NUBURU participates in the program through a structured economic and governance framework that includes pricing and margin participation, capital coordination, and potential integration of higher-margin non-kinetic and software subsystems. The Company also maintains a 2.9% equity position in Tekne, with potential expansion subject to Italian Government authorization under Golden Power regulation.

This structure enables NUBURU to participate in program economics as production scales while supporting its broader Defense & Security platform strategy.

Management Commentary

Alessandro Zamboni, Executive Chairman and Co-CEO of NUBURU, stated, “The entry into production marks the transition from structured agreement to executing program. This is now an operational industrial initiative aligned with Ukraine deployment requirements and supported by a validated supply chain.”

Dario Barisoni, Co-CEO of NUBURU and CEO of Nuburu Defense LLC, added, “We have achieved alignment across engineering, production, and local industrial capabilities. The program is progressing through a defined qualification and deployment pathway with coordinated execution.”

Strategic Outlook

With production underway, validated industrial readiness, and revenue-generating activities initiated, NUBURU continues to transition from strategic framework development to execution of defense programs with real-world deployment and scalable revenue potential.

About Nuburu, Inc

Founded in 2015, Nuburu is executing a strategic transformation from a laser-technology company into a dual-use Defense & Security platform provider. Through a combination of proprietary directed-energy technologies, non-kinetic defense capabilities, mission-critical software, and targeted industrial partnerships and acquisitions, Nuburu addresses high-value defense, security, and operational-resilience markets.

For more information, visit www.nuburu.net.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 319

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 283

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 462

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 81

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 246

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading

Top 5 Most Recently Viewed Articles

New Partnership Expands Eco-Friendly Solutions in the South

Updated Category News Views 234

Expanding Environmental Solutions in the Southern States Easy Environmental Solutions Inc., formerly known as Digital Utilities Ventures, is excited to announce a significant partnership with Organic Living Soil, LLC. As the exclusive dealer for Easy Environmental Solutions in Louisiana and Mississippi, Organic Living Soil aims to revolutionize the way eco-friendly...

Continue Reading
Michael Young Enhances Ty J. Young Wealth Management Team

Updated Category News Views 244

Michael Young Joins Ty J. Young Wealth Management Ty J. Young Wealth Management, a prominent name in financial services, proudly announces the appointment of Michael Young as Vice President of Business Development. With a wealth of experience from his previous role as a sales executive in a Fortune 500 company, Young is set to take the lead in expanding the firm's...

Continue Reading
Johnson & Johnson Advances Myeloma Treatment with FDA Application

Updated Category News Views 289

Johnson & Johnson took a big swing back in 2024 when they submitted a supplemental Biologics License Application (sBLA) for their myeloma treatment, DARZALEX FASPRO®. This move aimed at getting the green light from the FDA for use among newly diagnosed multiple myeloma patients who couldn't go through autologous stem cell transplants. Desks buzzed with chatter on how...

Continue Reading
What Investors Should Anticipate in ScanSource's Earnings Report

Updated Category News Views 121

ScanSource's Earnings Report: Expectations and Insights ScanSource (NASDAQ:SCSC) is gearing up to release its quarterly earnings report soon. Investors are particularly interested in the results that are expected to be announced shortly. With the anticipation building, understanding what to look for is essential. Predicted Earnings Results Industry experts have estimated...

Continue Reading
Revealing the Truth: IRS Data Access by Immigration Authorities

Updated Category News Views 127

IRS Data Accessed by Immigration Authorities: An Overview Federal immigration officials gained access to taxpayer information from the IRS during the previous administration's deportation efforts, though they claim this data was not used to identify individuals for removal. This raises serious questions surrounding privacy and immigration enforcement. Cross-Referencing...

Continue Reading